- Home
- CWK vs VCYT Comparison
CWK vs VCYT Comparison
Compare CWK & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CWK | VCYT |
|---|---|---|
| Founded | 1784 | 2006 |
| Country | United States | United States |
| Employees | 53000 | N/A |
| Industry | Real Estate | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 2.8B |
| IPO Year | 2018 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CWK | VCYT |
|---|---|---|
| Price | $12.69 | $33.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $18.07 | ★ $46.50 |
| AVG Volume (30 Days) | ★ 3.0M | 811.0K |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | 0.38 | ★ 0.82 |
| Revenue | ★ $10,288,200,000.00 | N/A |
| Revenue This Year | $2.17 | $13.33 |
| Revenue Next Year | $5.87 | $12.53 |
| P/E Ratio | ★ $34.83 | $42.30 |
| Revenue Growth | ★ 8.91 | N/A |
| 52 Week Low | $7.82 | $22.61 |
| 52 Week High | $17.40 | $50.71 |
Technical Indicators
Market Signals| Indicator | CWK | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 36.23 | 38.15 |
| Support Level | $11.37 | $32.51 |
| Resistance Level | $16.89 | $34.89 |
| Average True Range (ATR) | 0.69 | 1.49 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 21.74 | 12.19 |
Price Performance
Historical ComparisonAbout CWK Cushman & Wakefield plc
Cushman & Wakefield is one of the largest commercial real estate services firms in the world, with global headquarters in Chicago. The firm provides various real estate-related services to owners, occupiers, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such as valuation, project management, and facilities management.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.